-
Crude prices plunge, stocks surge as US and Iran agree ceasefire
-
Wave of nostalgia as 2000s TV makes a comeback
-
Iraqi armed group releases US journalist
-
Forest's Igor Jesus eyes Europa League 'dream', Villa brace for Bologna in quarters
-
In-demand prop De Lutiis rebuffs Ireland to commit to Australia
-
US, Iran agree to 11th-hour truce after Trump apocalyptic threats
-
Trump suspends Iran bombing for two weeks, after apocalyptic threats
-
Latest Anthropic AI model finds cracks in software defenses
-
McIlroy chases Masters repeat at lightning-fast Augusta
-
Arsenal's Raya hailed as 'world's best keeper' after denying Sporting
-
Bayern's Kompany praises 'special' Neuer display in win at Real Madrid
-
Diaz, Kane give Bayern vital Champions League win at Real
-
Havertz strikes late as Arsenal steal Champions League advantage against Sporting
-
Pakistan makes last-minute bid to avert Trump threat to destroy Iran
-
Artemis II crew basks in glow of lunar flyby en route to Earth
-
Global stocks mostly fall ahead of Trump's deadline for Iran
-
Trump weighs plea for Iran deadline extension
-
Artemis and ISS astronauts share celestial call
-
Former Romania coach Lucescu dies aged 80
-
'Nice to get a 2nd chance': Slot tips Liverpool to bounce back against PSG
-
Iran says ready for anything after Trump warns 'whole civilization will die'
-
French couple head home after more than three years in Iranian jail
-
Jaiswal, Sooryavanshi fire Rajasthan to win in rain-hit IPL clash
-
Extra Masters security eases anxiety battle for Woodland
-
Atletico's Simeone hails 'exemplary' departing Griezmann
-
Relaxed McIlroy finds new challenges after Masters win
-
Russia, China veto UN resolution on reopening Strait of Hormuz
-
Indigenous groups demand greater land protection in Brazil protest
-
Fitzpatrick tries to balance goals ahead of Masters
-
Trump branded 'crazy' over apocalyptic Iran threats
-
Vance hails Orban as 'model' for Europe in pre-election Hungary visit
-
McIlroy starting with Young, Howell in Masters repeat bid
-
Picasso's 'Guernica' at heart of battle in Spain over location
-
Isak named in Liverpool squad for PSG clash after long injury absence
-
Young says rise up rankings gives him belief for Masters
-
Artemis II crew snaps historic Earthset photo on way home
-
Seixas climbs to victory to extend Basque Tour lead
-
Oil rises, stocks fall ahead of Trump's Iran deadline
-
With Legos, trolling and Twain, Iran pushes war narrative on social media
-
Rahm confident of playing '27 Ryder Cup and DP World Tour
-
French couple leave Iran after more than three years in detention
-
NASA releases picture of 'Earthset' shot by Artemis crew
-
Major dreams and Middle East War in Fleetwood's Masters thoughts
-
Trump warns 'whole civilization will die' in Iran if ultimatum expires
-
Sinner and Alcaraz start fast on Monte Carlo clay in race for No.1
-
UK government blocks Kanye West from London music fest
-
Oil rises, stocks fall as Trump's Iran deadline looms
-
Graft trial of Spanish PM's ex-top aide begins
-
French high-speed train slams into truck, killing TGV driver
-
Kanye West offers to meet UK Jewish community amid music fest row
Charlie's Holdings (OTCQB:CHUC) Selected for FDA Premarket Tobacco Product Applications Meeting
Charlie's Director, Dr. Ed Carmines, an expert on regulatory submissions and product safety, will discuss Pharmacological Profiles at the prestigious FDA roundtable.
COSTA MESA, CA / ACCESS Newswire / February 10, 2026 / Charlie's Holdings, Inc.(OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Center for Tobacco Products of the U.S. Food and Drug Administration ("FDA") selected Charlie's Board member, Ed Carmines, PhD, to serve as a panelist for the Roundtable on Premarket Tobacco Product Application ("PMTA") Submissions for Electronic Nicotine Delivery Systems ("ENDS") that will be held at 9:00am (Eastern Time) today at FDA Headquarters in Silver Spring, Maryland.
Dr. Ed Carmines, Chief Scientific Officer of Chemular, Inc, and independent Board Member of Charlie's Holdings, is a world-renowned expert in the technical aspects of all types of e-cigarettes, oral tobacco, tobacco-free products, cigars, and cigarettes. Having successfully navigated the FDA's Substantial Equivalence, PMTA, and Modified Risk Tobacco Product Application ("MRTPA") pathways for literally thousands of products, Dr. Carmines spearheaded development and licensing of proprietary technology to enable Charlie's to offer a controlled e-cigarette device that is made operable only upon activation by an age-verified adult consumer.
By launching this strategic initiative, Charlie's has endeavored to make the Company's PACHA™ disposable e-cigarette products the first flavored e-cigarettes able to be sold legally in the United States.
During today's FDA roundtable, Dr. Carmines will discuss pharmacokinetic studies around Charlie's PACHA products as well as studies of adult benefits related to flavored ENDS products that could result in Charlie's becoming the first Company to demonstrate to the FDA that age-gated flavored vape products are indeed 'appropriate for the protection of public health.'
The FDA roundtable discussion will be available for viewing online.
For more information about providing comments, orally or in writing, please see the Federal Register notice.
About Charlie's Holdings, Inc.
Charlie's Holdings, Inc. (OTCQB:CHUC) is an industry leader in the premium vapor products space. The Company's products are sold around the world to select distributors, specialty retailers, and third-party online resellers through subsidiary company Charlie's Chalk Dust, LLC has developed an extensive portfolio of brand styles, flavor profiles, and innovative product formats.
For additional information, please visit Charlie's corporate website at: Chuc.comand the Company's branded online websites: sbxvape.com, CharliesChalkDust.com, enjoypachamama.com, and Pacha.co.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company's overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as "expect," "anticipate," "should," "believe," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "could," "intend," variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The Company's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company's ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company's ability to successfully increase sales and enter new markets; whether the Company's PMTA's for its nicotine-containing products will be authorized by the FDA, and the FDA's decisions with respect to the Company's future PMTA's for nicotine products; the Company's ability to manufacture and produce products for its customers; the Company's ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, products containing nicotine substitutes, and products containing cannabidiol; litigation risks from the use of the Company's products; risks of government regulations; the impact of competitive products; and the Company's ability to maintain and enhance its brands, as well as other risk factors included in the Company's most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.
Investors Contact:
[email protected]
Phone: 949-570-0691
SOURCE: Charlie's Holdings, Inc.
View the original press release on ACCESS Newswire
M.O.Allen--AT